Health & Environmental Research Online (HERO)


Print Feedback Export to File
180690 
Journal Article 
Enhancing safety with potassium phosphates injection 
Cornish, P; Hyland, S; Koczmara, C 
2007 
0 
Dynamics
ISSN: 1497-3715 
18 
4 
34-36 
English 
18274363 
The inadvertent administration of concentrated potassium chloride resulting in patient death is well-documented in Canada and other countries. Vials of potassium phosphates contain more than twice the concentration of potassium compared to vials of potassium chloride concentrate. If inadequately diluted or administered too rapidly, intravenous potassium phosphate can also lead to serious patient harm. This article contains information reprinted with permission from an ISMP Canada Safety Bulletin (ISMP Canada, 2006, April 25) for the purpose of enhancing safety with potassium phosphates injection. 
Adverse Drug Reaction Reporting Systems; Canada/ep [Epidemiology]; Drug Labeling; Drug Packaging; Health Planning Guidelines; Health Services Needs and Demand; Humans; Infusions, Intravenous; Injections, Intravenous; Medication Errors/mo [Mortality]; *Medication Errors/pc [Prevention & Control]; Medication Errors/sn [Statistics & Numerical Data]; Phosphates/ad [Administration & Dosage]; Phosphates/ae [Adverse Effects]; *Phosphates; Potassium Compounds/ad [Administration & Dosage]; Potassium Compounds/ae [Adverse Effects]; *Potassium Compounds; *Safety Management/og [Organization & Administration]; 0 (Phosphates); 0 (Potassium Compounds); 16068-46-5 (potassium phosphate)